Dosing of erythropoiesis-stimulating agents can be reduced by a new administration regimen
{{output}}
Background/aims: At our hemodialysis (HD) unit, we noted a drop in the treatment dose of erythropoietin-stimulating agents (ESAs) when the frequency of dose adjustment was reduced from weekly, where doses were withheld if hemoglo... ...
